Sep05 ASCPT News, September 2019
Stay up to date with the latest information about clinical pharmacology, therapeutics, and transla...
Sep03 FDA News: Issue 28, August 2019
FDA Approves XENLETA (Lefamulin) Injection and Tablets for the Treatment of Adults with Community-Ac...
Sep01 September 2019: Member Spotlight
Eleftheria Tsakalozou, PhD, Staff Fellow/Science Reviewer, Division of Quantitative Methods and Mode...
Sep01 September 2019: Dedicated Member
Ganesh M. Mugundu, MPharm, PhD, Director, Clinical Pharmacology–Oncology, AstraZeneca, Boston, MA
Sep01 September 2019: Student/Trainee Profile
Kana Mizuno, PhD, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Aug28 FDA News: Issue 27, August 2019
FDA Approves Pretomanid Tablets for use as Part of a Combination Regimen with Bedaquiline and Linezo...
Aug22 ASCPT Members-Only Webinar presented by the Biologics Community
Development of Talimogene Laherparepvec, First FDA Approved Genetically Modified Oncolytic Virus: ...
Aug20 FDA News: Issue 26, August 2019
FDA Approves ROZLYTREK (Entrectinib) for
ROS1 -Positive Non-Small Cell Lung Cancer in Adul...
Aug19 FDA News: Issue 25, August 2019
FDA Approves WAKIX (Pitolisant) for the Treatment of Excessive Daytime Sleepiness (EDS) in Adult ...
Aug16 FDA News: Issue 24, August 2019
FDA Announces Availability of the Draft Guidance "Population Pharmacokinetics"